Supernus Pharmaceuticals (NASDAQ:SUPN) Issues Earnings Results
Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) announced its quarterly earnings results on Wednesday. The specialty pharmaceutical company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.42), Briefing.com reports. Supernus Pharmaceuticals had a return on equity of 2.83% and a net margin of 4.20%. The business had […]
More Stories
Who is George Russell? Number 63 Driver of Formula One Racing
If you follow car racing closely, you must know who is George Russell. One who started as a kart racer...
What is Project Management? 5 Best Project Management Tools that You Can Try
Are you also looking for the best project management tool that will help you automate repetitive tasks and save time?...
US Sent B-1 Bombers ‘Deep Inside Iran,’ CENTCOM Says
By Jack Phillips The U.S. military sent B-1 bombers “deep inside Iran” to target the Iranian regime’s ballistic missile systems...
Iranians Celebrate After Leader Khamenei Killed in US–Israeli Strike
By Omid Ghoreishi Videos from Iran show people in different cities across the country celebrating in the streets after Islamic...
Dow Jones Drops 500 Points, Oil Surges 8 Percent at Opening Bell
By Andrew Moran U.S. stocks fell and crude oil prices surged at the March 2 opening bell as investors reacted...
DHS Interdicts 6 Suspected Smuggling Vessels, Captures 82 Migrants off California Coast
By Naveen Athrappully Six suspected human smuggling boats were taken into custody by authorities during the weekend, the Department of...